Faculty Opinions recommendation of Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.731686267.793564931 ◽

2019 ◽

Author(s):

Dafna Gladman

Keyword(s):

Psoriatic Arthritis ◽

Signs And Symptoms ◽

Phase 3 ◽

Download Full-text

THU0322 Secukinumab provides sustained improvements in the signs and symptoms of active psoriatic arthritis: 3-year results from the phase 3 future 2 study

10.1136/annrheumdis-2018-eular.2379 ◽

2018 ◽

Author(s):

P. Nash ◽

I.B. McInnes ◽

P. Rahman ◽

A.B. Gottlieb ◽

B. Kirkham ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Signs And Symptoms ◽

Phase 3 ◽

Download Full-text

Secukinumab improves signs and symptoms of psoriatic arthritis: Results of phase 3 FUTURE 2 study stratified by concomitant methotrexate use

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2016.02.1044 ◽

2016 ◽

Vol 74 (5) ◽

pp. AB270

Keyword(s):

Psoriatic Arthritis ◽

Signs And Symptoms ◽

Phase 3 ◽

Download Full-text

OP0222 Secukinumab provides sustained improvements in the signs and symptoms of active psoriatic arthritis: 104 weeks results from a phase 3 trial, future 2

10.1136/annrheumdis-2017-eular.1274 ◽

2017 ◽

Author(s):

IB McInnes ◽

PJ Mease ◽

C Ritchlin ◽

P Rahman ◽

A Gottlieb ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Signs And Symptoms ◽

Phase 3 ◽

Download Full-text

Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study

Rheumatology ◽

10.1093/rheumatology/kex301 ◽

2017 ◽

Vol 56 (11) ◽

pp. 1993-2003 ◽

Author(s):

Iain B McInnes ◽

Philip J Mease ◽

Christopher T Ritchlin ◽

Proton Rahman ◽

Alice B Gottlieb ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Signs And Symptoms ◽

Phase 3 ◽

Download Full-text

THU0425 Secukinumab Improves Signs and Symptoms of Active Psoriatic Arthritis in a Phase 3 Randomized, Multicenter, Double-Blind, Placebo-Controlled Study Using a Subcutaneous Dosing Regimen (Future 2)

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2015-eular.2265 ◽

2015 ◽

Vol 74 (Suppl 2) ◽

pp. 352.3-353 ◽

Author(s):

I.B. McInnes ◽

P. Mease ◽

B. Kirkham ◽

A. Kavanaugh ◽

C. Ritchlin ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Signs And Symptoms ◽

Controlled Study ◽

Dosing Regimen ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

256 Secukinumab provides sustained improvements in the signs and symptoms of active psoriatic arthritis: 4-year results from the Phase 3 FUTURE 2 study

Rheumatology ◽

10.1093/rheumatology/kez107.072 ◽

2019 ◽

Vol 58 (Supplement_3) ◽

Author(s):

Iain B McInnes ◽

Bruce Kirkham ◽

Peter Nash ◽

Proton Rahman ◽

Alice B Gottlieb ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Signs And Symptoms ◽

Phase 3 ◽

Download Full-text

FRI0430 IXEKIZUMAB IMPROVES THE SIGNS AND SYMPTOMS OF PSORIATIC ARTHRITIS REGARDLESS OF SEX, DURATION OF DISEASE, OR BODY MASS INDEX IN TWO RANDOMIZED, PHASE 3 CLINICAL TRIALS

10.1136/annrheumdis-2019-eular.1474 ◽

2019 ◽

Author(s):

Lihi Eder ◽

Satish Odhav ◽

Mariusz Korkosz ◽

Aubrey Trevelin Sprabery ◽

Amanda M. Gellett ◽

...

Keyword(s):

Body Mass Index ◽

Clinical Trials ◽

Psoriatic Arthritis ◽

Body Mass ◽

Signs And Symptoms ◽

Phase 3 ◽

Duration Of Disease

Download Full-text

Tofacitinib in psoriatic arthritis patients: skin signs and symptoms and health‐related quality of life from two randomized phase 3 studies

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.16433 ◽

2020 ◽

Vol 34 (12) ◽

pp. 2809-2820 ◽

Author(s):

J.F. Merola ◽

K.A. Papp ◽

P. Nash ◽

J. Gratacós ◽

W.H. Boehncke ◽

...

Keyword(s):

Quality Of Life ◽

Psoriatic Arthritis ◽

Signs And Symptoms ◽

Health Related Quality ◽

Phase 3 ◽

Related Quality ◽

Health Related ◽

Download Full-text

LB0001 Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24 week results of a phase 3 double blind randomized placebo-controlled study (rapid-PSA)

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2012-eular.1961 ◽

2013 ◽

Vol 71 (Suppl 3) ◽

pp. 150.3-151 ◽

Author(s):

P.J. Mease ◽

R. Fleischmann ◽

A. Deodhar ◽

J. Wollenhaupt ◽

D. Kielar ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Certolizumab Pegol ◽

Signs And Symptoms ◽

Controlled Study ◽

Phase 3 ◽

Download Full-text

FRI0463 Secukinumab Improves Minimal Disease Activity Response Rates in Patients with Active Psoriatic Arthritis: Data from The Randomized Phase 3 Study, Future 2

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2016-eular.3949 ◽

2016 ◽

Vol 75 (Suppl 2) ◽

pp. 605.1-605 ◽

Author(s):

L.C. Coates ◽

P. Mease ◽

B. Kirkham ◽

L.D. McLeod ◽

S. Mpofu ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Disease Activity ◽

Response Rates ◽

Minimal Disease Activity ◽

Phase 3 ◽

Activity Response ◽

Minimal Disease ◽

Download Full-text